Sugi Predict

Sugi Predict / Compounds / SCHEMBL3347019

SCHEMBL3347019

SCHEMBL3347019

CCOC(=O)C(C(=O)OCC)c1cc(N)c(C)cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ CYP4F2 P78329 1/20 0.36
▸ CYP4A11 Q02928 1/20 0.36
▸ ABCB1 P08183 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ CPB2 Q96IY4 1/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ POLB P06746 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ GFER P55789 1/20 0.35
▸ MMP8 P22894 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ LMNA P02545 3/20 0.34
▸ HTT P42858 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343596 0.88 GPR35 (0.38) GPR35MEN1KMT2ACYP4F2CYP4A11
SCHEMBL3347024 0.78 MAPT (0.34) GAAPOLBGFERSMN1; SMN2NPC1
SCHEMBL3341272 0.78 CYP3A4 (0.44) MEN1KMT2ACYP4F2CYP4A11GAA
SCHEMBL13532054 0.76 KMT2A (0.38) MEN1KMT2AGAACPB2HSD17B10
SCHEMBL2126313 0.75 ALDH1A1 (0.44) GAANPSR1ALDH1A1LMNASMN1; SMN2
SCHEMBL1432899 0.74 CYP3A4 (0.47) MEN1KMT2AALDH1A1LMNAHTT
SCHEMBL5004400 0.73 CASP1 (0.41) MEN1KMT2ACYP4F2CYP4A11NPSR1
SCHEMBL5593462 0.72 NR3C2 (0.47) CASP1TSHR
SCHEMBL3340926 0.72 TDP1 (0.41) KMT2ASMN1; SMN2RAB9A
SCHEMBL27842550 0.72 POLB (0.38) GAAPOLBGFERLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288552-B2 Dihydropyridone amidesas P2X7 modulators ROCHE PALO ALTO LLC (US) 2012-10-16 — — US disclosed
US-8288552-B2 Dihydropyridone amidesas P2X7 modulators ROCHE PALO ALTO LLC (US) 2012-10-16 — — US disclosed
US-8288552-B2 Dihydropyridone amidesas P2X7 modulators ROCHE PALO ALTO LLC (US) 2012-10-16 — — US disclosed
EP-2391604-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS F. Hoffmann-La Roche AG (CH) 2011-12-07 — — EP disclosed
CN-102264702-A As P2X7Dihydropyridinone amides as modulators — 2011-11-30 — — CN disclosed
WO-2010072605-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2010-07-01 — — WO disclosed
WO-2010072605-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2010-07-01 — — WO disclosed
US-20100160389-A1 DIHYDROPYRIDONE AMIDESAS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 — — US disclosed
US-20100160389-A1 DIHYDROPYRIDONE AMIDESAS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 — — US disclosed
US-20100160389-A1 DIHYDROPYRIDONE AMIDESAS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160389-A1 DIHYDROPYRIDONE AMIDESAS P2X7 MODULATORS P2RX3, P2RX1, P2RY1 GPR35 147/4885MEN1 3352/4885KMT2A 3040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.